The result also concurred with the hypothesis for the progression of lung adenocarcinoma that EGFR-mutated AAH follows a linear progression schema, whereby AAH progresses to AIS and is followed by MIA (20, 21). Here, EGFR is linked to lung adenocarcinoma.